News tagged with boehringer ingelheim

Linagliptin: Once again, no proof of added benefit

Linagliptin (trade name Trajenta) has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market ...

Medications Jan 30, 2013 | not rated yet | 0

FDA panel backs long-acting Boehringer inhaler

(AP)—A panel of federal health experts is overwhelmingly recommending approval for a long-acting inhaler to treat people suffering from chronic lung disease.

Medications Jan 29, 2013 | not rated yet | 0